Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer

Respirology

Volumn 12, Issue 1, 2007, Pages 137-139

  Yamaguchi, Hiroyuki ^a   Soda, Hiroshi ^a   Kitazaki, Takeshi ^a   Nakano, Hirofumi ^a   Fujino, Satoru ^a   Nakamura, Yoichi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

PET; ProGRP; Small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IRINOTECAN; PROGASTRIN RELEASING PEPTIDE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; EARLY DIAGNOSIS; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REFERENCE VALUE; SMOKING; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BODY RADIATION;

AGED; CARCINOMA, SMALL CELL; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PEPTIDE FRAGMENTS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33845716412     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00966.x     Document Type: Article

References (8)

1. Molina R, Filella X, Auge JM. ProGRP: a new biomarker for small cell lung cancer. Clin. Biochem. 2004; 37: 505-11.
2. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004; 231: 305-32.
3. 18F-FDG PET improves the management of patients with small cell lung cancer. J. Nucl. Med. 2003; 44: 1911-7.
4. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J. Clin. Oncol. 2004; 16: 3248-54.
5. 18F]FDG-PET on the primary staging of small-cell lung cancer. Eur. J. Nucl. Med. Mol. Imaging 2004; 31: 1614-20.
6. Turrisi AT, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N. Engl. J. Med. 1999; 340: 265-71.
7. Niho S, Nishiwaki Y, Goto K et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoemboryonic antigen. Lung Cancer 2000; 27: 159-67.
8. Okusaka T, Eguchi K, Kasai T et al. Serum levels of progastrin-releasing peptide for follow-up of patients with small cell lung cancer. Clin. Cancer Res. 1997; 3: 123-7.